Carna Biosciences Inc
TSE:4572
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Carna Biosciences Inc
TSE:4572
|
JP |
|
B
|
Bioasis Technologies Inc
OTC:BIOAF
|
US |
|
A
|
Ardelyx Inc
F:41X
|
US |
|
Solocal Group SE
F:QS30
|
FR |
|
Instone Real Estate Group SE
XETRA:INS
|
DE |
|
I
|
Ipsen SA
OTC:IPSEF
|
FR |
|
P
|
Premier American Uranium Inc
XTSX:PUR
|
CA |
|
Catalyst Metals Ltd
ASX:CYL
|
AU |
|
China Southern Airlines Co Ltd
F:ZNHH
|
CN |
|
K
|
Konami Holdings Corp
LSE:KNM
|
JP |
|
NAHL Group PLC
LSE:NAH
|
UK |
|
C
|
Com2uS Holdings Corp
KOSDAQ:063080
|
KR |
|
PPHE Hotel Group Ltd
LSE:PPH
|
NL |
|
B
|
British Land Company PLC
F:BLD
|
UK |
|
A
|
Allstate Corp
F:ALS
|
US |
|
Brookfield Corp
TSX:BN
|
CA |
|
Y
|
Yokohama Rubber Co Ltd
F:YRB
|
JP |
|
C
|
China Life Insurance Co Ltd
OTC:CILJF
|
CN |
|
R
|
Regions Financial Corp
XMUN:RN7
|
US |
|
Viel et Compagnie SA
F:VIC
|
FR |
|
D
|
Deep Yellow Ltd
XMUN:JMI
|
AU |
|
I Synergy Group Ltd
ASX:IS3
|
AU |
Shareholder Yield
Current shareholder yield for Carna Biosciences Inc is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Carna Biosciences Inc
| Average Annual Return | -11.16% |
| Standard Deviation of Annual Returns | 34.44% |
| Max Drawdown | -85% |
| Market Capitalization | 8.9B JPY |
| Shares Outstanding | 20 650 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Carna Biosciences Inc's latest stock split occurred on Dec 26, 2013
The company executed a 100-for-1 stock split, meaning that for every share held, investors received 100 new shares.
Before the split, Carna Biosciences Inc traded at 698 per share. Afterward, the share price was about 756.
The adjusted shares began trading on Dec 26, 2013. This was the only stock split in Carna Biosciences Inc's history.